• 1
    Rozga J, Williams F, Ro M-S, Neuzil DF, Giorgio TD, Backfisch G, et al. Development of a bioartificial liver: properties and function of a hollow-fibre module inoculated with liver cells. Hepatology 1993; 17: 258265.
  • 2
    Sussman NL, Chong MG, Koussayer T, He D, Shang TA, Whisennand HH, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16: 6065.
  • 3
    Jauregui HO, Gann KL. Mammalian hepatocytes as a foundation for treatment in human liver failure. J Cellular Biochem 1991; 45: 359365.
  • 4
    Nyberg SL, Shatford RA, Hu W-S, Payne WD, Cerra FB. Hepatocyte culture systems for artificial liver support: Implications for critical care medicine (bioartificial liver support). Crit Care Med 1992; 20: 11571168.
  • 5
    Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 1966; 18: 118125.
  • 6
    Rozga J, Holzman MD, Ro M-S, Griffin DW, Neuzil DF, Giorgio T, et al. Development of a hybrid bioartificial liver. Ann Surg 1993; 217: 502511.
  • 7
    O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal haemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 11861192.
  • 8
    Rozga J, Podesta L, LePage E, Morsiani E, Moscioni AD, Hoffman H, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 5: 538546.
  • 9
    Hilgier W, Olson JE. Brain ion and amino acid contents during oedema development in hepatic encephalopathy. J Neurochem 1994; 62: 197204.
  • 10
    Rozga J, Podesta L, Lepage E, Hoffman A, Morsiani E, Sher L, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342: 898899.
  • 11
    Sussman NL, Gislason G, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artificial Organs 1994; 18: 390396.
  • 12
    Hughes RD, Williams R. Clinical experience with charcoal and resin haemoperfusion. Semin Liver Dis 1986; 6: 164173.
  • 13
    Ozawa K, Aoyama H, Yasuda K, Shimahara Y, Nakatani T, Tanaka J, et al. Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch Surg 1983; 118: 12451251.
  • 14
    Hughes RD, Cochrane AMG, Thomson AD, Murray-Lyon IM, Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Path 1976; 57: 348353.
  • 15
    Wendon JA, Sheron N, Harrison PM, Keane H, Alexander GJM, Williams R. Correlation of cytokine values with haemodynamic and oxygen transport variables in fulminant hepatic failure [Abstract]. Gut 1991; 32: A577.
  • 16
    Ellis AJ, Wendon J, Hughes R, Langley P, Sussman NL, Kelly JH, et al. A controlled trial of the Hepatix extracorporeal liver assist device (ELAD) in acute liver failure [Abstract]. Hepatology 1994; 20: 140A.
  • 17
    O'Grady JG, Alexander GL, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439445.
  • 18
    Berk PD, Goldberg JD. Charcoal hemoperfusion plus ça change, plus c'est la měme chose. Gastroenterology 1988; 94: 12281230.
  • 19
    Hughes RD, Zhang L, Tsubouchi H, Daikuhara Y, Williams R. Plasma hepatocyte growth factor and biliprotein levels in fulminant hepatic failure. J Hepatol 1994; 20: 106111.
  • 20
    Yamada H, Toda G, Yoshiba M, Ikeda Y, Mitsui H, Kurokawa K, et al. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant hepatic failure. Hepatology 1994; 19: 11331140.
  • 21
    Gerlach JC, Encke J, Hole O, Muller C, Courtney JM, Neuhaus P. Hepatocyte culture between three dimensionally arranged biomatrix-coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments. Int J Artif Organs 1994; 17: 301306.
  • 22
    Gibson-D'Ambrosio RE, Crowe DL, Shuler CE, D'Ambrosio SM. The establishment and continuous subculturing of normal human adult hepatocytes: expression of differentiated liver functions. Cell Biol Toxicol 1993; 9: 385403.